for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Syngene International Ltd

SYNN.NS

Latest Trade

325.60INR

Change

5.70(+1.78%)

Volume

53,248

Today's Range

319.10

 - 

329.00

52 Week Range

250.05

 - 

369.00

As of on the National Stock Exchange of India ∙ Minimum 15 minute delay

Latest Developments

India's Syngene International Reports Rise In Sept Qtr Net Profit

Oct 22 (Reuters) - Syngene International Ltd <SYNN.NS>::SEPT QUARTER NET PROFIT 1.28 BILLION RUPEES VERSUS 783 MILLION RUPEES YEAR AGO.SEPT QUARTER REVENUE FROM OPERATIONS 4.65 BILLION RUPEES VERSUS 4.19 BILLION RUPEES YEAR AGO.

India's Syngene International Dec-Qtr Profit Rises

Jan 22 (Reuters) - Syngene International Ltd <SYNN.NS>::DEC QUARTER CONSOL PROFIT 870 MILLION RUPEES VERSUS 820 MILLION RUPEES YEAR AGO.DEC QUARTER CONSOL REVENUE FROM OPERATIONS 4.67 BILLION RUPEES VERSUS 3.88 BILLION RUPEES YEAR AGO.

Syngene International Expands Collaboration With Baxter Healthcare Corp

July 23 (Reuters) - Syngene International Ltd <SYNN.NS>::SAYS EXPANDED SCOPE OF ITS RESEARCH AND DEVELOPMENT COLLABORATION WITH BAXTER HEALTHCARE CORPORATION.AS PART OF EXPANSION, SYNGENE WILL SET UP ADDITIONAL INFRASTRUCTURE AT DEDICATED BAXTER GLOBAL RESEARCH CENTER (BGRC).AS PART OF EXPANSION, SYNGENE WILL INCREASE THE SIZE OF ITS SCIENTIFIC TEAM WORKING ON BAXTER PROJECTS .DURATION OF THE AGREEMENT HAS ALSO BEEN EXTENDED UNTIL 2024 .

India's Biocon, Biocon Research Cut Stake In Syngene International

May 24 (Reuters) - Biocon Ltd <BION.NS>::CO, BIOCON RESEARCH CUT STAKE IN SYNGENE INTERNATIONAL BY 2.80 PERCENT TO 70.74 PERCENT.

Syngene International Says Promoter Biocon Proposes To Divest Part Of Its Shareholding In Co

May 15 (Reuters) - Syngene International Ltd <SYNN.NS>::SAYS PROMOTER BIOCON PROPOSES TO DIVEST PART OF ITS SHAREHOLDING IN CO.

India's Syngene International March-Qtr Profit Rises

April 25 (Reuters) - Syngene International Ltd <SYNN.NS>::MARCH QUARTER PROFIT 843 MILLION RUPEES VERSUS PROFIT OF 784 MILLION RUPEES YEAR AGO.MARCH QUARTER REVENUE FROM OPERATIONS 4.09 BILLION RUPEES VERSUS 2.91 BILLION RUPEES YEAR AGO.RECOMMENDED FINAL DIVIDEND OF 1 RUPEE PER SHARE.

India's Syngene International Dec-Qtr Profit Rises

Jan 23 (Reuters) - Syngene International Ltd <SYNN.NS>::DEC QUARTER PROFIT 819 MILLION RUPEES VERSUS PROFIT 744 MILLION RUPEES YEAR AGO.DEC QUARTER REVENUE FROM OPERATIONS 3.88 BILLION RUPEES VERSUS 3.32 BILLION RUPEES YEAR AGO.

Bristol-Myers and Syngene expand ongoing research collaboration

Nov 14 (Reuters) - Syngene International <SYNN.NS>::Bristol-Myers Squibb and Syngene International expand ongoing research collaboration.Says collaboration with Bristol-Myers Squibb extended until 2026​.

Syngene International ‍expands collaboration with Bristol-Myers Squibb​

Nov 14 (Reuters) - Syngene International Ltd <SYNN.NS>::Says ‍expanded collaboration with Bristol-Myers Squibb​.Nnext phase of partnership will see addition of facility to support future Bristol-Myers Squibb research and development operations​.

India's Syngene International Sept-qtr profit rises 3 pct

Oct 25 (Reuters) - Syngene International Ltd <SYNN.NS>:Sept quarter net profit 769 million rupees versus profit of 747 million rupees last year.Sept quarter revenue from operations 3.35 billion rupees versus 3.03 billion rupees last year.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up